Kloetzel, P. M. Antigen processing by the proteasome. Nat. Rev. Mol. Cell Biol. 2, 179–187 (2001).
PubMed
Article
CAS
PubMed Central
Google Scholar
Coulie, P. G. et al. A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma. Proc. Natl Acad. Sci. USA 92, 7976–7980 (1995).
PubMed
PubMed Central
Article
CAS
Google Scholar
Roche, P. A. & Furuta, K. The ins and outs of MHC class II-mediated antigen processing and presentation. Nat. Rev. Immunol. 15, 203–216 (2015).
PubMed
PubMed Central
Article
CAS
Google Scholar
Yewdell, J. W., Reits, E. & Neefjes, J. Making sense of mass destruction: quantitating MHC class I antigen presentation. Nat. Rev. Immunol. 3, 952–961 (2003).
PubMed
Article
CAS
PubMed Central
Google Scholar
Schumacher, T. N., Scheper, W. & Kvistborg, P. Cancer neoantigens. Annu. Rev. Immunol. 37, 173–200 (2019).
PubMed
Article
CAS
PubMed Central
Google Scholar
Bianchi, V., Harari, A. & Coukos, G. Neoantigen-specific adoptive cell therapies for cancer: making T-cell products more personal. Front. Immunol. 11, 1215 (2020).
PubMed
PubMed Central
Article
CAS
Google Scholar
Curran, M. A. & Glisson, B. S. New hope for therapeutic cancer vaccines in the era of immune checkpoint modulation. Annu. Rev. Med. 70, 409–424 (2019).
PubMed
Article
CAS
PubMed Central
Google Scholar
Haen, S. P., Löffler, M. W., Rammensee, H.-G. & Brossart, P. Towards new horizons: characterization, classification and implications of the tumour antigenic repertoire. Nat. Rev. Clin. Oncol. 17, 595–610 (2020).
PubMed
Article
PubMed Central
Google Scholar
Kruger, S. et al. Advances in cancer immunotherapy 2019: latest trends. J. Exp. Clin. Cancer Res. 38, 268 (2019).
PubMed
PubMed Central
Article
Google Scholar
Christofi, T., Baritaki, S., Falzone, L., Libra, M. & Zaravinos, A. Current perspectives in cancer immunotherapy. Cancers (Basel) 11, 1472 (2019).
Article
CAS
Google Scholar
Laumont, C. M. et al. Global proteogenomic analysis of human MHC class I-associated peptides derived from non-canonical reading frames. Nat. Commun. 7, 10238 (2016).
PubMed
PubMed Central
Article
CAS
Google Scholar
Sebestyen, E. et al. Large-scale analysis of genome and transcriptome alterations in multiple tumors unveils novel cancer-relevant splicing networks. Genome Res. 26, 732–744 (2016).
PubMed
PubMed Central
Article
CAS
Google Scholar
Zhao, Q. et al. Proteogenomics uncovers a vast repertoire of shared tumor-specific antigens in ovarian cancer. Cancer Immunol. Res. 8, 544–555 (2020).
PubMed
Article
CAS
PubMed Central
Google Scholar
Ouspenskaia, T. et al. Thousands of novel unannotated proteins expand the MHC I immunopeptidome in cancer. Preprint at bioRxiv https://doi.org/10.1101/2020.02.12.945840 (2020).
Chen, J. et al. Pervasive functional translation of noncanonical human open reading frames. Science 367, 1140–1146 (2020).
PubMed
PubMed Central
Article
CAS
Google Scholar
Ilyas, S. & Yang, J. C. Landscape of tumor antigens in T cell immunotherapy. J. Immunol. 195, 5117–5122 (2015).
PubMed
Article
CAS
PubMed Central
Google Scholar
Caballero, O. L. & Chen, Y. T. Cancer/testis (CT) antigens: potential targets for immunotherapy. Cancer Sci. 100, 2014–2021 (2009).
PubMed
Article
CAS
PubMed Central
Google Scholar
Tio, D. et al. Expression of cancer/testis antigens in cutaneous melanoma: a systematic review. Melanoma Res. 29, 349–357 (2019).
PubMed
Article
PubMed Central
Google Scholar
Schooten, E., Di Maggio, A., van Bergen En Henegouwen, P. M. P. & Kijanka, M. M. MAGE-A antigens as targets for cancer immunotherapy. Cancer Treat. Rev. 67, 54–62 (2018).
PubMed
Article
CAS
PubMed Central
Google Scholar
D’Angelo, S. P. et al. Antitumor activity associated with prolonged persistence of adoptively transferred NY-ESO-1 c259T cells in synovial. Sarcoma 8, 944–957 (2018).
Google Scholar
Rapoport, A. P. et al. NY-ESO-1–specific TCR–engineered T cells mediate sustained antigen-specific antitumor effects in myeloma. Nat. Med. 21, 914–921 (2015).
PubMed
PubMed Central
Article
CAS
Google Scholar
Robbins, P. F. et al. A pilot trial using lymphocytes genetically engineered with an NY-ESO-1–reactive T-cell receptor: long-term follow-up and correlates with response. Clin. Cancer Res. 21, 1019–1027 (2015).
PubMed
Article
CAS
PubMed Central
Google Scholar
Laumont, C. M. & Perreault, C. Exploiting non-canonical translation to identify new targets for T cell-based cancer immunotherapy. Cell. Mol. Life Sci. 75, 607–621 (2018).
PubMed
Article
CAS
PubMed Central
Google Scholar
Moreau-Aubry, A. et al. A processed pseudogene codes for a new antigen recognized by a CD8+ T cell clone on melanoma. J. Exp. Med. 191, 1617–1623 (2000).
PubMed
PubMed Central
Article
CAS
Google Scholar
Li, L.-J., Leng, R.-X., Fan, Y.-G., Pan, H.-F. & Ye, D.-Q. Translation of noncoding RNAs: focus on lncRNAs, pri-miRNAs, and circRNAs. Exp. Cell Res. 361, 1–8 (2017).
PubMed
Article
CAS
PubMed Central
Google Scholar
Charpentier, M. et al. IRES-dependent translation of the long non coding RNA meloe in melanoma cells produces the most immunogenic MELOE antigens. Oncotarget 7, 59704–59713 (2016).
PubMed
PubMed Central
Article
Google Scholar
Roulois, D. et al. DNA-demethylating agents target colorectal cancer cells by inducing viral mimicry by endogenous transcripts. Cell 162, 961–973 (2015).
PubMed
PubMed Central
Article
CAS
Google Scholar
Chiappinelli, K. B. et al. Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses. Cell 162, 974–986 (2015).
PubMed
PubMed Central
Article
CAS
Google Scholar
Attermann, A. S., Bjerregaard, A. M., Saini, S. K., Gronbaek, K. & Hadrup, S. R. Human endogenous retroviruses and their implication for immunotherapeutics of cancer. Ann. Oncol. 29, 2183–2191 (2018).
PubMed
Article
CAS
PubMed Central
Google Scholar
Vigneron, N. et al. An antigenic peptide produced by peptide splicing in the proteasome. Science 304, 587–590 (2004).
PubMed
Article
CAS
PubMed Central
Google Scholar
Delong, T. et al. Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion. Science 351, 711–714 (2016).
PubMed
PubMed Central
Article
CAS
Google Scholar
Yewdell, J. W. & Holly, J. DRiPs get molecular. Curr. Opin. Immunol. 64, 130–136 (2020).
PubMed
Article
CAS
PubMed Central
Google Scholar
Welters, M. J. et al. Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine. Clin. Cancer Res. 14, 178–187 (2008).
PubMed
Article
CAS
PubMed Central
Google Scholar
Morgan, R. A. et al. Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy. J. Immunother. 36, 133–151 (2013).
PubMed
PubMed Central
Article
CAS
Google Scholar
Skipper, J. C. et al. Mass-spectrometric evaluation of HLA-A*0201-associated peptides identifies dominant naturally processed forms of CTL epitopes from MART-1 and gp100. Int J. Cancer 82, 669–677 (1999).
PubMed
Article
CAS
PubMed Central
Google Scholar
Wolf, B. et al. Safety and tolerability of adoptive cell therapy in cancer. Drug Saf. 42, 315–334 (2019).
PubMed
Article
CAS
PubMed Central
Google Scholar
Purcell, A. W., Ramarathinam, S. H. & Ternette, N. Mass spectrometry-based identification of MHC-bound peptides for immunopeptidomics. Nat. Protoc. 14, 1687–1707 (2019).
PubMed
Article
CAS
PubMed Central
Google Scholar
Caron, E. et al. Analysis of major histocompatibility complex (MHC) immunopeptidomes using mass spectrometry. Mol. Cell. Proteom. 14, 3105–3117 (2015).
Article
CAS
Google Scholar
Ritz, D., Kinzi, J., Neri, D. & Fugmann, T. Data-independent acquisition of HLA class I peptidomes on the Q exactive mass spectrometer platform. Proteomics 17, 1700177 (2017).
Article
CAS
Google Scholar
Gillet, L. C. et al. Targeted data extraction of the MS/MS spectra generated by data-independent acquisition: a new concept for consistent and accurate proteome analysis. Mol. Cell. Proteom. 11, O111.016717 (2012).
Article
CAS
Google Scholar
Brunner, A.-D. et al. Ultra-high sensitivity mass spectrometry quantifies single-cell proteome changes upon perturbation. Preprint at bioRxiv 2020.2012.2022.423933 (2020).
Tsou, C. C. et al. DIA-Umpire: comprehensive computational framework for data-independent acquisition proteomics. Nat. Methods 12, 258–264 (2015).
PubMed
PubMed Central
Article
CAS
Google Scholar
Muntel, J. et al. Surpassing 10 000 identified and quantified proteins in a single run by optimizing current LC-MS instrumentation and data analysis strategy. Mol. Omics 15, 348–360 (2019).
PubMed
Article
CAS
PubMed Central
Google Scholar
Gessulat, S. et al. Prosit: proteome-wide prediction of peptide tandem mass spectra by deep learning. Nat. Methods 16, 509–518 (2019).
PubMed
Article
CAS
PubMed Central
Google Scholar
Croft, N. P. et al. Kinetics of antigen expression and epitope presentation during virus infection. PLoS Pathog. 9, e1003129 (2013).
PubMed
PubMed Central
Article
CAS
Google Scholar
Hassan, C. et al. Accurate quantitation of MHC-bound peptides by application of isotopically labeled peptide MHC complexes. J. Proteom. 109, 240–244 (2014).
Article
CAS
Google Scholar
Croft, N. P., Purcell, A. W. & Tscharke, D. C. Quantifying epitope presentation using mass spectrometry. Mol. Immunol. 68, 77–80 (2015).
PubMed
Article
CAS
PubMed Central
Google Scholar
Tan, C. T., Croft, N. P., Dudek, N. L., Williamson, N. A. & Purcell, A. W. Direct quantitation of MHC-bound peptide epitopes by selected reaction monitoring. Proteomics 11, 2336–2340 (2011).
PubMed
Article
CAS
PubMed Central
Google Scholar
Kapp, E. A. et al. An evaluation, comparison, and accurate benchmarking of several publicly available MS/MS search algorithms: sensitivity and specificity analysis. Proteomics 5, 3475–3490 (2005).
Kapp, E. & Schutz, F. Overview of tandem mass spectrometry (MS/MS) database search algorithms. Curr. Protoc. Protein Sci. 49, 25.2.1–25.2.19 (2007).
Article
Google Scholar
Elias, J. E. & Gygi, S. P. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat. Methods 4, 207–214 (2007).
PubMed
Article
CAS
PubMed Central
Google Scholar
Zhang, J. et al. PEAKS DB: de novo sequencing assisted database search for sensitive and accurate peptide identification. Mol. Cell. Proteom. 11, M111.010587 (2012).
Article
CAS
Google Scholar
Shan, P. & Tran, H. Integrating database search and de novo sequencing for immunopeptidomics with DIA approach. J. Biomol. Tech. 30, S23 (2019).
PubMed Central
Google Scholar
Faridi, P., Purcell, A. W. & Croft, N. P. In immunopeptidomics we need a sniper instead of a shotgun. Proteomics 18, e1700464 (2018).
PubMed
Article
CAS
PubMed Central
Google Scholar
Thompson, A. et al. Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS. Anal. Chem. 75, 1895–1904 (2003).
PubMed
Article
CAS
PubMed Central
Google Scholar
Pfammatter, S. et al. Extending the comprehensiveness of immunopeptidome analyses using isobaric peptide labeling. Anal. Chem. 92, 9194–9204 (2020).
PubMed
Article
CAS
PubMed Central
Google Scholar
Ramarathinam, S. H. et al. A peptide-signal amplification strategy for the detection and validation of neoepitope presentation on cancer biopsies. Preprint at bioRxiv https://doi.org/10.1101/2020.06.12.145276 (2020).
Stopfer, L. E., Mesfin, J. M., Joughin, B. A., Lauffenburger, D. A. & White, F. M. Multiplexed relative and absolute quantitative immunopeptidomics reveals MHC I repertoire alterations induced by CDK4/6 inhibition. Nat. Commun. 11, 2760 (2020).
PubMed
PubMed Central
Article
CAS
Google Scholar
d’Atri, V. et al. Adding a new separation dimension to MS and LC–MS: what is the utility of ion mobility spectrometry? J. Sep. Sci. 41, 20–67 (2018).
PubMed
Article
CAS
PubMed Central
Google Scholar
Pfammatter, S. et al. A novel differential ion mobility device expands the depth of proteome coverage and the sensitivity of multiplex proteomic measurements. Mol. Cell. Proteom. 17, 2051–2067 (2018).
Article
CAS
Google Scholar
Pfammatter, S., Bonneil, E. & Thibault, P. Improvement of quantitative measurements in multiplex proteomics using high-field asymmetric waveform spectrometry. J. Proteome Res. 15, 4653–4665 (2016).
PubMed
Article
CAS
PubMed Central
Google Scholar
Meier, F. et al. Online parallel accumulation-serial fragmentation (PASEF) with a novel trapped ion mobility mass spectrometer. Mol. Cell. Proteom. 17, 2534–2545 (2018).
Article
CAS
Google Scholar
Nesvizhskii, A. I. Proteogenomics: concepts, applications and computational strategies. Nat. Methods 11, 1114–1125 (2014).
PubMed
PubMed Central
Article
CAS
Google Scholar
Zhang, M. et al. RNA editing derived epitopes function as cancer antigens to elicit immune responses. Nat. Commun. 9, 3919 (2018).
PubMed
PubMed Central
Article
CAS
Google Scholar
Wei, Z. et al. The landscape of tumor fusion neoantigens: a pan-cancer. Anal. iScience 21, 249–260 (2019).
Article
Google Scholar
Löffler, M. W. et al. Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma. Genome Med. 11, 28 (2019).
PubMed
PubMed Central
Article
Google Scholar
Kalaora, S. et al. Use of HLA peptidomics and whole exome sequencing to identify human immunogenic neo-antigens. Oncotarget 7, 5110–5117 (2016).
PubMed
PubMed Central
Article
Google Scholar
Bassani-Sternberg, M., Pletscher-Frankild, S., Jensen, L. J. & Mann, M. Mass spectrometry of human leukocyte antigen class I peptidomes reveals strong effects of protein abundance and turnover on antigen presentation. Mol. Cell. Proteom. 14, 658–673 (2015).
Article
CAS
Google Scholar
Khodadoust, M. S. et al. Antigen presentation profiling reveals recognition of lymphoma immunoglobulin neoantigens. Nature 543, 723–727 (2017).
PubMed
PubMed Central
Article
CAS
Google Scholar
Bassani-Sternberg, M. et al. Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry. Nat. Commun. 7, 13404 (2016).
PubMed
PubMed Central
Article
CAS
Google Scholar
Binz, P. A. et al. Proteomics Standards Initiative extended FASTA format. J. Proteome Res. 18, 2686–2692 (2019).
PubMed
PubMed Central
Article
CAS
Google Scholar
Eng, J. K. & Deutsch, E. W. Extending comet for global amino acid variant and post-translational modification analysis using the PSI extended FASTA format. Proteomics 72, e1900362 (2020).
Article
CAS
Google Scholar
Elias, J. E. & Gygi, S. P. Target-decoy search strategy for mass spectrometry-based proteomics. Methods Mol. Biol. 604, 55–71 (2010).
PubMed
PubMed Central
Article
CAS
Google Scholar
Gupta, N., Bandeira, N., Keich, U. & Pevzner, P. A. Target-decoy approach and false discovery rate: when things may go wrong. J. Am. Soc. Mass Spectrom. 22, 1111–1120 (2011).
PubMed
PubMed Central
Article
CAS
Google Scholar
Tanner, S. et al. Improving gene annotation using peptide mass spectrometry. Genome Res. 17, 231–239 (2007).
PubMed
PubMed Central
Article
CAS
Google Scholar
Chong, C. et al. Integrated proteogenomic deep sequencing and analytics accurately identify non-canonical peptides in tumor immunopeptidomes. Nat. Commun. 11, 1293 (2020).
PubMed
PubMed Central
Article
CAS
Google Scholar
Laumont, C. M. et al. Noncoding regions are the main source of targetable tumor-specific antigens. Sci. Transl. Med. 10, eaau5516 (2018).
PubMed
Article
CAS
PubMed Central
Google Scholar
Smart, A. C. et al. Intron retention is a source of neoepitopes in cancer. Nat. Biotechnol. 36, 1056–1058 (2018).
PubMed
PubMed Central
Article
CAS
Google Scholar
Attig, J. et al. LTR retroelement expansion of the human cancer transcriptome and immunopeptidome revealed by de novo transcript assembly. Genome Res. 29, 1578–1590 (2019).
PubMed
PubMed Central
Article
CAS
Google Scholar
Kong, Y. et al. Transposable element expression in tumors is associated with immune infiltration and increased antigenicity. Nat. Commun. 10, 5228 (2019).
PubMed
PubMed Central
Article
CAS
Google Scholar
Shraibman, B., Melamed Kadosh, D., Barnea, E. & Admon, A. HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy. Mol. Cell. Proteom. 15, 3058–3070 (2016).
Article
CAS
Google Scholar
Calviello, L. et al. Detecting actively translated open reading frames in ribosome profiling data. Nat. Methods 13, 165–170 (2016).
PubMed
Article
CAS
PubMed Central
Google Scholar
Erhard, F. et al. Improved Ribo-seq enables identification of cryptic translation events. Nat. Methods 15, 363–366 (2018).
PubMed
PubMed Central
Article
CAS
Google Scholar
Ingolia, N. T. et al. Ribosome profiling reveals pervasive translation outside of annotated protein-coding genes. Cell Rep. 8, 1365–1379 (2014).
PubMed
PubMed Central
Article
CAS
Google Scholar
Slavoff, S. A. et al. Peptidomic discovery of short open reading frame–encoded peptides in human cells. Nat. Chem. Biol. 9, 59–64 (2013).
PubMed
Article
CAS
PubMed Central
Google Scholar
Sarkizova, S. et al. A large peptidome dataset improves HLA class I epitope prediction across most of the human population. Nat. Biotechnol. 38, 199–209 (2020).
PubMed
Article
CAS
PubMed Central
Google Scholar
Abelin, J. G. et al. Mass spectrometry profiling of HLA-associated peptidomes in mono-allelic cells enables more accurate epitope prediction. Immunity 46, 315–326 (2017).
PubMed
PubMed Central
Article
CAS
Google Scholar
Warren, E. H. et al. An antigen produced by splicing of noncontiguous peptides in the reverse order. Science 313, 1444–1447 (2006).
PubMed
Article
CAS
PubMed Central
Google Scholar
Dalet, A. et al. An antigenic peptide produced by reverse splicing and double asparagine deamidation. Proc. Natl Acad. Sci. USA 108, E323–E331 (2011).
PubMed
PubMed Central
Article
Google Scholar
Michaux, A. et al. A spliced antigenic peptide comprising a single spliced amino acid is produced in the proteasome by reverse splicing of a longer peptide fragment followed by trimming. J. Immunol. 192, 1962–1971 (2014).
PubMed
Article
CAS
PubMed Central
Google Scholar
Hanada, K., Yewdell, J. W. & Yang, J. C. Immune recognition of a human renal cancer antigen through post-translational protein splicing. Nature 427, 252–256 (2004).
PubMed
Article
CAS
PubMed Central
Google Scholar
Liepe, J. et al. A large fraction of HLA class I ligands are proteasome-generated spliced peptides. Science 354, 354–358 (2016).
PubMed
Article
CAS
PubMed Central
Google Scholar
Faridi, P. et al. A subset of HLA-I peptides are not genomically templated: evidence for cis- and trans-spliced peptide ligands. Sci. Immunol. 3, eaar3947 (2018).
PubMed
Article
PubMed Central
Google Scholar
Liepe, J., Sidney, J., Lorenz, F. K. M., Sette, A. & Mishto, M. Mapping the MHC class I–spliced immunopeptidome of cancer cells. Cancer Immunol. Res. 7, 62–76 (2019).
PubMed
Article
CAS
PubMed Central
Google Scholar
Paes, W. et al. Contribution of proteasome-catalyzed peptide cis-splicing to viral targeting by CD8+ T cells in HIV-1 infection. Proc. Natl Acad. Sci. USA 116, 24748–24759 (2019).
PubMed
PubMed Central
Article
CAS
Google Scholar
Faridi, P. et al. Spliced peptides and cytokine-driven changes in the immunopeptidome of melanoma. Cancer Immunol. Res. 8, 1322–1334 (2020).
PubMed
Article
CAS
PubMed Central
Google Scholar
Mylonas, R. et al. Estimating the contribution of proteasomal spliced peptides to the HLA-I ligandome. Mol. Cell. Proteom. 17, 2347–2357 (2018).
Article
CAS
Google Scholar
Rolfs, Z., Solntsev, S. K., Shortreed, M. R., Frey, B. L. & Smith, L. M. Global identification of post-translationally spliced peptides with neo-fusion. J. Proteome Res. 18, 349–358 (2019).
PubMed
CAS
PubMed Central
Google Scholar
Erhard, F., Dölken, L., Schilling, B. & Schlosser, A. Identification of the cryptic HLA-I immunopeptidome. Cancer Immunol. Res. 8, 1018–1026 (2020).
PubMed
Article
CAS
PubMed Central
Google Scholar
Vigneron, N., Ferrari, V., Stroobant, V., Abi Habib, J. & Van den Eynde, B. J. Peptide splicing by the proteasome. J. Biol. Chem. 292, 21170–21179 (2017).
PubMed
PubMed Central
Article
CAS
Google Scholar
Dalet, A., Vigneron, N., Stroobant, V., Hanada, K. & Van den Eynde, B. J. Splicing of distant peptide fragments occurs in the proteasome by transpeptidation and produces the spliced antigenic peptide derived from fibroblast growth factor-5. J. Immunol. 184, 3016–3024 (2010).
PubMed
Article
CAS
PubMed Central
Google Scholar
Henry, V. J., Bandrowski, A. E., Pepin, A. S., Gonzalez, B. J. & Desfeux, A. OMICtools: an informative directory for multi-omic data analysis. Database (Oxford) 2014, bau069 (2014).
Article
CAS
Google Scholar
Afgan, E. et al. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update. Nucleic Acids Res. 46, W537–W544 (2018).
PubMed
PubMed Central
Article
CAS
Google Scholar
Nesvizhskii, A. I. et al. Dynamic spectrum quality assessment and iterative computational analysis of shotgun proteomic data: toward more efficient identification of post-translational modifications, sequence polymorphisms, and novel peptides. Mol. Cell. Proteom. 5, 652–670 (2006).
Article
CAS
Google Scholar
Andreatta, M. et al. MS-Rescue: a computational pipeline to increase the quality and yield of immunopeptidomics experiments. Proteomics 19, e1800357 (2019).
PubMed
Article
CAS
PubMed Central
Google Scholar
Rolfs, Z., Müller, M., Shortreed, M. R., Smith, L. M. & Bassani-Sternberg, M. Comment on ‘A subset of HLA-I peptides are not genomically templated: evidence for cis- and trans-spliced peptide ligands’. Sci. Immunol. 4, eaaw1622 (2019).
PubMed
PubMed Central
Article
CAS
Google Scholar
McGranahan, N. & Swanton, C. Clonal heterogeneity and tumor evolution: past, present, and the future. Cell 168, 613–628 (2017).
PubMed
Article
CAS
PubMed Central
Google Scholar
Marcu, A. et al. The HLA Ligand Atlas. A resource of natural HLA ligands presented on benign tissues. J. Immunother. Cancer 9, e002071 (2019).
Article
Google Scholar
Schatton, T. et al. Identification of cells initiating human melanomas. Nature 451, 345–349 (2008).
PubMed
PubMed Central
Article
CAS
Google Scholar
Lang, D., Mascarenhas, J. B. & Shea, C. R. Melanocytes, melanocyte stem cells, and melanoma stem cells. Clin. Dermatol. 31, 166–178 (2013).
PubMed
PubMed Central
Article
Google Scholar
Kassiotis, G. & Stoye, J. P. Immune responses to endogenous retroelements: taking the bad with the good. Nat. Rev. Immunol. 16, 207–219 (2016).
PubMed
Article
CAS
PubMed Central
Google Scholar
Rycaj, K. et al. Cytotoxicity of human endogenous retrovirus K–specific T cells toward autologous ovarian. Cancer Cells 21, 471–483 (2015).
CAS
Google Scholar
Saini, S. K. et al. Human endogenous retroviruses form a reservoir of T cell targets in hematological cancers. Nat. Commun. 11, 5660 (2020).
PubMed
PubMed Central
Article
CAS
Google Scholar
Mullins, C. S. & Linnebacher, M. Endogenous retrovirus sequences as a novel class of tumor-specific antigens: an example of HERV-H env encoding strong CTL epitopes. Cancer Immunol. Immun. 61, 1093–1100 (2012).
Article
CAS
Google Scholar
Tu, X. et al. Human leukemia antigen-A*0201-restricted epitopes of human endogenous retrovirus W family envelope (HERV-W env) induce strong cytotoxic T lymphocyte responses. Virol. Sin. 32, 280–289 (2017).
PubMed
PubMed Central
Article
CAS
Google Scholar
Belgnaoui, S. M., Gosden, R. G., Semmes, O. J. & Haoudi, A. Human LINE-1 retrotransposon induces DNA damage and apoptosis in cancer cells. Cancer Cell Int. 6, 13 (2006).
PubMed
PubMed Central
Article
CAS
Google Scholar
Scott, E. C. et al. A hot L1 retrotransposon evades somatic repression and initiates human colorectal cancer. Genome Res. 26, 745–755 (2016).
PubMed
PubMed Central
Article
CAS
Google Scholar
Ott, P. A. et al. An immunogenic personal neoantigen vaccine for patients with melanoma. Nature 547, 217–221 (2017).
PubMed
PubMed Central
Article
CAS
Google Scholar
Sahin, U. et al. Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer. Nature 547, 222–226 (2017).
PubMed
Article
CAS
PubMed Central
Google Scholar
Ebrahimi-Nik, H. et al. Mass spectrometry driven exploration reveals nuances of neoepitope-driven tumor rejection. JCI Insight 5, e129152 (2019).
Article
Google Scholar
Smith, C. C. et al. Alternative tumour-specific antigens. Nat. Rev. Cancer 19, 465–478 (2019).
PubMed
PubMed Central
Article
CAS
Google Scholar
Jackson, R. et al. The translation of non-canonical open reading frames controls mucosal immunity. Nature 564, 434–438 (2018).
PubMed
PubMed Central
Article
CAS
Google Scholar
Muller, M., Gfeller, D., Coukos, G. & Bassani-Sternberg, M. ‘Hotspots’ of antigen presentation revealed by human leukocyte antigen ligandomics for neoantigen prioritization. Front. Immunol. 8, 1367 (2017).
PubMed
PubMed Central
Article
CAS
Google Scholar
Schittenhelm, R. B. et al. A comprehensive analysis of constitutive naturally processed and presented HLA-C*04:01 (Cw4)-specific peptides. Tissue Antigen. 83, 174–179 (2014).
Article
CAS
Google Scholar
Schuster, H. et al. The immunopeptidomic landscape of ovarian carcinomas. Proc. Natl Acad. Sci. USA 114, E9942–E9951 (2017).
PubMed
PubMed Central
Article
CAS
Google Scholar
Sarkizova, S. et al. A large peptidome dataset improves HLA class I epitope prediction across most of the human population. Nat. Biotechnol. 38, 199–209 (2020).
PubMed
Article
CAS
PubMed Central
Google Scholar
Keskin, D. B. et al. Neoantigen vaccine generates intratumoral T cell responses in Phase Ib glioblastoma trial. Nature 565, 234–239 (2019).
PubMed
Article
CAS
PubMed Central
Google Scholar
Shraibman, B. et al. Identification of tumor antigens among the HLA peptidomes of glioblastoma tumors and plasma. Mol. Cell. Proteom. 17, 2132–2145 (2018).
Article
CAS
Google Scholar
Ternette, N. et al. Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer identifies potential immunotherapy target antigens. Proteomics 18, 1700465 (2018).
PubMed Central
Article
CAS
Google Scholar